COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details) - Level 3 - Contingent Consideration Liability - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Arkis BioSciences, Inc.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ 12,895	$ 15,099
Additions		0
Change in fair value of contingent consideration liabilities	(2,860)	2,204
Balance, end of period	15,755	12,895
Arkis BioSciences, Inc. | Accrued expenses and other current liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	2,845
Balance, end of period	7,778	2,845
Arkis BioSciences, Inc. | Other liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	10,050
Balance, end of period	7,977	10,050
Derma Sciences
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	230	230
Additions		0
Change in fair value of contingent consideration liabilities	(2,327)	0
Balance, end of period	2,557	230
Derma Sciences | Accrued expenses and other current liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	0
Balance, end of period	0	0
Derma Sciences | Other liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	230
Balance, end of period	2,557	230
ACell
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	3,700	21,800
Additions		0
Change in fair value of contingent consideration liabilities	3,400	18,100
Balance, end of period	300	3,700
ACell | Accrued expenses and other current liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	0
Balance, end of period	0	0
ACell | Other liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	3,700
Balance, end of period	300	3,700
Surgical Innovation Association Inc
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	57,607	0
Additions		57,607
Change in fair value of contingent consideration liabilities	(11,093)
Balance, end of period	68,700	57,607
Surgical Innovation Association Inc | Accrued expenses and other current liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	0
Balance, end of period	13,400	0
Surgical Innovation Association Inc | Other liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	57,607
Balance, end of period	$ 55,300	$ 57,607